• Xenon Pharmaceuticals granted 24,250 share options and 14,250 restricted share units to nine new non-officer employees.
• The grants took effect October 29, 2026; each option has a 10-year term.
• Options vest 25% on employees' first start-date anniversary, with 1/36 of remaining options vesting monthly thereafter on each month's last day.
• Restricted share units vest 25% on each of the grant date's first four anniversaries.
• All vesting is subject to continued service with the company.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xenon Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610301601PRIMZONEFULLFEED9856923) on October 30, 2026, and is solely responsible for the information contained therein.